RTTNews | Jan 11, 2022 10:58AM EST

10:57 Tuesday, January 11, 2022 (RTTNews.com) - Shares of biotechnology company Illumina, Inc. (ILMN) are up 8 percent on Tuesday's trading after the company announced a multi-year agreement with Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center or VUMC to accelerate medicines development via large-scale genomics and the setting up of a pre-eminent clinico-genomic resource.

By using Illumina's next-generation sequencing platforms, scientists and researchers will be able to better identify disease associations and targets for intervention by analyzing data.

Currently, at $394.12, the stock has traded between $341.03 and $555.77 during the past 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3254322/illumina-shares-rise-8-on-agreement-with-nashville-biosciences.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2022 RTTNews.com All Rights Reserved